Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 15/3/20061 min de lectura
Guidance for Industry on Nonclinical Safety Evaluation of Drug or Biologic Combinations; Availability
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Nonclinical Safety Evaluation of Drug or Biologic Combinations." This guidance provides recommendations on nonclinical approaches to support the clinical study and approval of fixed-dose combination products (FDCs), co-packaged products, and some adjunctive therapies.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →